Literature DB >> 482734

In vitro studies on resealed erythrocyte ghosts as protein carriers.

U Sprandel, A R Hubbard, R A Chalmers.   

Abstract

Resealed erythrocyte ghosts have been proposed as in vivo carriers for enzyme replacement therapy of inherited metabolic diseases. In comparative studies of methods for reversible hypotonic haemolysis of erythrocytes, a five-fold increased entrapment of human serum albumin was obtained by use of a dialysis procedure instead of direct dilution. The percentage incorporation of protein was also affected by varying mixing procedure, haematocrit, lysis, and resealing times but not by varying buffer composition or added protein concentrations over a wide range. Higher protein entrapment was observed with time-expired blood compared to fresh blood and this may be ascribed to increased osmotic fragility of the erythrocyte membrane in stored cells. Haemolysed and resealed ghosts prepared by any method used were smaller than normal erythrocytes as measured with a Coulter Counter and with a fluorescence-activated cell sorter, and protein entrapment reduced the ghost size further.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 482734     DOI: 10.1007/bf01851280

Source DB:  PubMed          Journal:  Res Exp Med (Berl)        ISSN: 0300-9130


  4 in total

1.  Laboratory-scale finned-rotor impeller for dialysis.

Authors:  M A el-Kalay; A E Nasser
Journal:  Med Biol Eng Comput       Date:  1989-09       Impact factor: 2.602

Review 2.  Engineering antiphagocytic biomimetic drug carriers.

Authors:  Alicia Sawdon; Ching-An Peng
Journal:  Ther Deliv       Date:  2013-07

3.  Towards enzyme therapy using carrier erythrocytes.

Authors:  U Sprandel; A R Hubbard; R A Chalmers
Journal:  J Inherit Metab Dis       Date:  1981       Impact factor: 4.982

4.  Organic-acid transport in resealed haemoglobin-containing human erythrocyte 'ghosts'.

Authors:  A R Hubbard; U Sprandel; R A Chalmers
Journal:  Biochem J       Date:  1980-09-15       Impact factor: 3.857

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.